Skip to main content

Table 4 AS&AQ groups: crude and PCR-adjusted Day 28 efficacy results presented by site and country

From: Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis

Efficacy by Day 28 by country and site *

Number of patients enrolled receiving ASAQ

Crude (not adjusted for reinfection)

PCR-adjusted

  

Efficacy

Lower 95% confidence interval

Upper 95% confidence interval

Efficacy

Lower 95% confidence interval

Upper 95% confidence interval

Angola (all)

166

92.0%

83.0%

96.3%

98.6%

90.5%

99.8%

   Angola-Caala

69

91.0%

81.1%

95.9%

98.4%

89.3%

99.8%

   Angola-Kuito

97

92.9%

84.9%

96.8%

98.8%

91.7%

99.8%

Burkina Faso (all)

923

96.7%

91.4%

97.5%

NA

NA

NA

   Burkina Faso-Bobo-Dilaossou

33

100%

91.3%

100.0%

NA

NA

NA

   Burkina Faso-Pouytenga

890

93.5%

91.5%

95.0%

97.3%

95.9%

98.2%

Cameroun-Mendong

110

98.1%

92.5%

99.5%

100.0%

100.0%

100.0%

Congo-Kindamba#

101

67.5%

57.0%

75.9%

84.2%

74.8%

90.4%

Gabon-Lambarene

110

87.5%

79.1%

92.7%

94.5%

87.3%

97.7%

Guinea-Dabola

110

94.4%

87.9%

97.4%

99.1%

93.6%

99.9%

Kenya-Migori#

200

76.5%

69.1%

82.4%

89.5%

83.4%

93.5%

Madagascar-Tsiroanomandidy

119

96.6%

91.2%

98.7%

99.2%

94.1%

99.9%

Mali (all)

387

74.5%

67.4%

80.4%

98.3%

94.6%

99.5%

   Mali-Bancoumana

135

68.5%

59.7%

75.7%

97.5%

92.3%

99.2%

   Mali-Bougoula

252

80.6%

75.1%

85.0%

99.2%

96.8%

99.8%

DRC (all)

136

74.5%

62.5%

82.0%

88.3%

76.6%

93.1%

   DRC-Boende#

90

57.7%

46.5%

67.4%

78.7%

67.6%

86.4%

   DRC-Kabalo

46

91.3%

78.5%

96.6%

97.8%

85.6%

99.7%

Rwanda (all)

410

82.4%

75.1%

87.5%

91.6%

85.6%

95.0%

   Rwanda-Kicukiro

122

91.6%

85.0%

95.4%

95.8%

90.2%

98.2%

   Rwanda-Mashesha

150

86.7%

80.1%

91.2%

95.3%

90.3%

97.7%

   Rwanda-Rukara#

138

68.8%

60.2%

75.9%

83.8%

76.1%

89.1%

Sénégal (all)

1390

96.1%

91.4%

98.5%

NA

NA

NA

   Senegal-Keur Socé

264

94.2%

90.9%

96.7%

99.2%

96.8%

99.8%

   Senegal-Djembeye

110

95.3%

91.3%

99.3%

NA

NA

NA

   Senegal-Kabrousse

27

100%

89.1%

100.0%

NA

NA

NA

   Senegal-Mlomp

883

95.8%

94.4%

97.2%

NA

NA

NA

   Senegal-Oussouye

106

95.3%

91.3%

99.3%

NA

NA

NA

Sierra-Leone-kailahun#

126

40.5%

31.5%

49.4%

87.5%

78.5%

92.9%

Sudan (all)

214

76.1%

66.8%

83.1%

88.4%

79.8%

93.4%

   South Sudan-Nuba#

80

63.8%

52.2%

73.2%

84.9%

74.4%

91.4%

   Sudan-Malakal

134

88.5%

81.3%

93.0%

91.8%

85.3%

95.5%

Uganda (all)

1283

53.3%

46.5%

59.6%

91.1%

85.1%

94.7%

   Uganda-Amudat#

106

30.3%

21.3%

39.9%

89.9%

79.2%

95.2%

   Uganda-Apac#

174

46.5%

38.9%

53.8%

87.2%

80.6%

91.7%

   Uganda-Arua#

174

49.3%

41.7%

56.6%

88.8%

82.5%

92.9%

   Uganda-Jinja

189

79.5%

72.9%

84.6%

94.3%

89.6%

96.9%

   Uganda-Kampala

242

83.8%

78.4%

87.9%

95.7%

92.1%

97.7%

   Uganda-Tororo

398

30.2%

25.7%

34.8%

91.1%

86.8%

94.0%

Zanzibar (all)

202

75.6%

64.9%

83.3%

91.8%

83.1%

96.2%

   Zanzibar-Kivunge

148

73.5%

65.5%

79.9%

95.0%

89.7%

97.6%

   Zanzibar-Micheweni#

54

77.8%

64.2%

86.7%

88.7%

76.5%

94.7%

  1. *Mean efficacies are given for countries with multiple sites
  2. # Efficacy PCR adjusted <90%
  3. NA: not applicable, no PCR genotyping data for all sites from that country